Does CAMRELIZUMAB Cause Myelosuppression? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Myelosuppression have been filed in association with CAMRELIZUMAB. This represents 16.3% of all adverse event reports for CAMRELIZUMAB.
70
Reports of Myelosuppression with CAMRELIZUMAB
16.3%
of all CAMRELIZUMAB reports
4
Deaths
29
Hospitalizations
How Dangerous Is Myelosuppression From CAMRELIZUMAB?
Of the 70 reports, 4 (5.7%) resulted in death, 29 (41.4%) required hospitalization, and 14 (20.0%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAMRELIZUMAB. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does CAMRELIZUMAB Cause?
Fatigue (60)
Nausea (60)
Vomiting (59)
Diarrhoea (54)
Anaemia (53)
Hypothyroidism (53)
Off label use (52)
Rash (50)
Thrombocytopenia (46)
Reactive capillary endothelial proliferation (41)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which CAMRELIZUMAB Alternatives Have Lower Myelosuppression Risk?
CAMRELIZUMAB vs CANAGLIFLOZIN
CAMRELIZUMAB vs CANAGLIFLOZIN\METFORMIN
CAMRELIZUMAB vs CANAKINUMAB
CAMRELIZUMAB vs CANDESARTAN
CAMRELIZUMAB vs CANDESARTAN CILEXETIL